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An 85-year-old man was admitted with dyspnea on exer-tion and general fatigue. He was a retired school teacher
without obvious history of asbestos exposure. Chest radio-
graph revealed cardiomegaly, and a large pericardial effusion
was found from echocardiogram, which was subsequently
drained by ultrasound-guided needle aspiration. Its hyal-
uronic acid level was 32,000 ng/ml (within normal range).
Cytologic examination was positive, suggesting adenocarci-
noma. The F-18 fluorodeoxyglucose positron emission to-
mography scan detected abnormal aggregations around the
ascending aorta, pulmonary artery, and pericardium, but no
primary focus was found (Figure 1). Pleural thickening and
pleural plaques were not detected. A diagnosis of adenocar-
cinoma and pericardial metastasis of unknown origin was
made. He died about 3 months after diagnosis due to right
cardiac failure resulting from constrictive pericarditis. Au-
topsy revealed tumor had infiltrated and proliferated in the
pericardium and myocardium and invaded the pericardial
cavity (Figure 2a). Tumor was not found in the pleura.
Pleural plaques were found, but asbestos bodies were not
observed. Histologic examination revealed atypical prolifer-
ation of epithelioid cells (Figure 2b) and spindle cells (Figure
2c). Immunologic staining for calretinin was positive in the
epithelioid and sarcomatous tumor cell nuclei and cytoplasm
(Figure 2d). We diagnosed diffuse and biphasic primary
malignant pericardial mesothelioma (PMPM).
PMPM is extremely rare and represents 0.7% of all
mesotheliomas.1 In this case, the patient was originally mis-
diagnosed with adenocarcinoma by pericardial effusion cy-
tology. The reliability of body cavity fluid cytology is low for
malignant mesothelioma; its sensitivity is reported to be 33 to
84%.2 Thus, histologic and immunohistochemical studies
should be performed when PMPM is clinically suspected,
even if adenocarcinoma is diagnosed by pericardial effusion
cytology.
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FIGURE 1. F-18 fluorodeoxyglucose positron emission to-
mography scan showing aggregations around the ascending
aorta, pulmonary artery, and the pericardium.
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FIGURE 2. a, Gross pathologic
specimen showing that the heart
was entirely encased with a yellow-
ish tumor occupying the pericardial
space. b, Histologic analysis revealed
atypical proliferation of epithelioid
cells forming large and small glan-
dular ducts (hematoxylin and eosin
stain; original magnification, 100).
c, Histologic analysis revealed atypi-
cal and irregular proliferation of
spindle cells (hematoxylin and eosin
stain; original magnification, 100).
d, Immunohistochemical staining for
calretinin was positive in the nuclei
and cytoplasm of the epithelioid
and sarcomatous tumor cells (origi-
nal magnification, 100).
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